Skip to main content
Log in

Effects of Melatonin, Aluminum Oxide, and Polymethylsiloxane Complex on the Expression of LYVE-1 in the Liver of Mice with Obesity and Type 2 Diabetes Mellitus

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The effects of melatonin, aluminum oxide, and polymethylsiloxane complex on the expression of LYVE-1 (lymphatic vessel endothelial hyaluronan receptor) in the liver were studied in db/db mice with experimental obesity and type 2 diabetes mellitus. The complex or placebo was administered daily by gavage from week 8 to week 16 of life. The animals receiving the complex exhibited enhanced, in comparison with the placebo group, immunohistochemical LYVE-1+ staining of endothelial cells in sinusoids. Enhanced expression of LYVE-1 was associated with less pronounced dilatation of interlobular arteries, veins, and lymphatic vessels. Thee findings suggest a protective effect of the complex towards structural changes in the liver of mice with obesity and type 2 diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Borodin YuI, Trufakin VA, Michurina SV, Shurlygina AV. Structural and temporal organization of the liver, lymphatic, immune, and endocrine systems under conditions of abnormal lighting regimen and melatonin treatment. Novosibirsk, 2012. Russian.

  2. Konenkov VI, Klimontov VV, Michurina SV, Prudnikova MA, Ishenko IJu. Melatonin and diabetes: from pathophysiology to the treatment perspectives. Sakh. Diabet. 2013;(2):11-16. Russian.

  3. 3 Konenkov VI, Borodin YuI, Lyubarskii MS. Lympholohy. Novosibirsk, 2012. Russian.

  4. Michurina SV, Rachkovskaja LN, Ishchenko IJ, Rachkovskij EE, Klimontov VV, Konenkov VI. Patent RF No. 2577580. Alumina-based porous sorbent with chronotropic properties. Bull. No. Published March 20, 2016.

  5. Rapoport SI, Golichenkova VA. Melatonin: Theory and Practics. Moscow, 2009. Russian.

  6. Arimoto J, Ikura Y, Suekane T, Nakagawa M, Kitabayashi C, Iwasa Y, Sugioka K, Naruko T, Arakawa T, Ueda M. Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers. J. Gastroenterol. 2010;45(3):317-325.

    Article  CAS  PubMed  Google Scholar 

  7. Bernaudin JF, Kambouchner M, Lacave R. Lymphatic vascular system, development and lymph formation. Review. Rev. Pneumol. Clin. 2013;69(2):93-101.

    Article  PubMed  Google Scholar 

  8. Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed. Pharmacother. 2006;60(3):97-108.

    Article  CAS  PubMed  Google Scholar 

  9. Hatzis G, Ziakas P, Kavantzas N, Triantafyllou A, Sigalas P, Andreadou I, Ioannidis K, Chatzis S, Filis K, Papalampros A, Sigala F. Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J. Hepatol. 2013;5(4):160-169.

    PubMed  PubMed Central  Google Scholar 

  10. Hu J, Srivastava K, Wieland M, Runge A, Mogler C, Besemfelder E, Terhardt D, Vogel MJ, Cao L, Korn C, Bartels S, Thomas M, Augustin HG. Endothelial cell-derived angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat. Science. 2014;343:416-419.

    Article  CAS  PubMed  Google Scholar 

  11. Martín M, Macías M, León J, Escames G, Khaldy H, Acuña-Castroviejo D. Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int. J. Biochem. Cell Biol. 2002;34(4):348-357.

    Article  PubMed  Google Scholar 

  12. Nagorny C, Lyssenko V. Tired of diabetes genetics? Circadian rhythms and diabetes: the MTNR1B story? Curr. Diab. Rep. 2012;12(6):667-672.

    Article  CAS  PubMed  Google Scholar 

  13. Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, Cardinali DP. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog. Neurobiol. 2008;85(3):335-353.

    Article  CAS  PubMed  Google Scholar 

  14. Peschke E. Melatonin, endocrine pancreas and diabetes. J. Pineal Res. 2008;44(1):26-40.

    CAS  PubMed  Google Scholar 

  15. Sahna E, Parlakpinar H, Vardi N, Ciğremis Y, Acet A. Efficacy of melatonin as protectant against oxidative stress and structural changes in liver tissue in pinealectomized rats. Acta Histochem. 2004;106(5):331-336.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. V. Michurina.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 162, No. 8, pp. 238-241, August, 2016

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Michurina, S.V., Ishchenko, I.Y., Arkhipov, S.A. et al. Effects of Melatonin, Aluminum Oxide, and Polymethylsiloxane Complex on the Expression of LYVE-1 in the Liver of Mice with Obesity and Type 2 Diabetes Mellitus. Bull Exp Biol Med 162, 269–272 (2016). https://doi.org/10.1007/s10517-016-3592-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-016-3592-y

Key Words

Navigation